secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptose Biosciences Inc. (APTOF)
CIK:        0000882361
Form:       8-K
Filed at:   2026-03-31T23:59:59+00:00
Accession:  0001193125-26-134870
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Aptose shareholders approve continuance to Alberta and Hanmi acquisition arrangement
--------------------------------------------------------------------------------

- Continuance from CBCA to Alberta approved with 92.42% votes in favor.
- Arrangement with Hanmi (HS North America Ltd.) approved with 84.87% votes in favor.
- Arrangement announced Nov 19, 2025; Hanmi to acquire all outstanding shares not already owned.
- Special meeting held March 31, 2026; all items passed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882361/000119312526134870/0001193125-26-134870-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882361/000119312526134870/d13408d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-134870

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer